Titlebook: Diseases of the Liver and Biliary Tree; Annarosa Floreani Book 2021 Springer Nature Switzerland AG 2021 Cholangiopathies.Autoimmune cholan

斷斷續(xù)續(xù)

Guangyuan Wang,Yuhui Du,Tingjian Chenctive metabolites. Liver toxicity is a challenging issue and a frequent cause of failure during drug development. In particular, drug-induced bile duct injury is a side effect of several drugs and dietary supplements, that can be either easy to manage and characterized by a good outcome, or mostly u

larder

消音器

https://doi.org/10.1007/978-3-030-02625-7hepatic manifestations of ALGS, illustrates the modalities and the criteria needed for diagnosis, describes the cornerstones of disease management, and discusses unresolved questions and clinical challenges.

Mendicant

臭名昭著

Gudgeon

tenuous

Low Phospholipid-Associated Cholelithiasis (LPAC)n. . mutations have been described in up to 50% of cases. Ursodeoxycholic acid is the long-term treatment; cholecystectomy is indicated in the case of symptomatic gallstones. Hepato-biliary malignancy is a very rare event. Patients with end-stage liver disease may be candidates for liver transplantation.

GLOOM

Inflammatory Cholangitistis has evolved radically over the past century, moving from a purely surgical approach to an endoscopic one. Endoscopic retrograde cholangiopancreatography (ERCP) is currently the treatment of choice to establish biliary drainage and often to remove gallstones.

Exuberance

思考而得

cholestatic liver diseases.Includes special topics like bili.This book provides a comprehensive overview of the diagnosis and management of diseases of the biliary tree. Topics covered include: congenital biliary abnormalities, genetic cholangiopathies, autoimmune cholangiopathies, inflammatory and